Literature DB >> 23781015

Results confounded by a disregard for basic dose-response radiobiology.

Yung Hsiang Kao.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23781015     DOI： 10.2967/jnumed.113.122846

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

Review 1.  Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

Authors:  Aaron K T Tong; Yung Hsiang Kao; Chow Wei Too; Kenneth F W Chin; David C E Ng; Pierce K H Chow
Journal:  Br J Radiol       Date:  2016-03-24       Impact factor: 3.039

2.  Yes, the Holy Gray exists. Learn from modern radioembolisation.

Authors:  Yung Hsiang Kao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-10       Impact factor: 9.236

3.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

4.  Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory.

Authors:  Wali Badar; Thuong Van Ha; Steven Zangan; Rakesh Navuluri; Anjana Pillai; Talia Baker; Leonard Dalag; Ross Han; Osman Ahmed
Journal:  Br J Radiol       Date:  2021-01-07       Impact factor: 3.039

5.  Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres.

Authors:  Yung-Hsiang Kao; Jeffrey D Steinberg; Young-Soon Tay; Gabriel Ky Lim; Jianhua Yan; David W Townsend; Charley A Budgeon; Jan A Boucek; Roslyn J Francis; Timothy St Cheo; Mark C Burgmans; Farah G Irani; Richard Hg Lo; Kiang-Hiong Tay; Bien-Soo Tan; Pierce Kh Chow; Somanesan Satchithanantham; Andrew Eh Tan; David Ce Ng; Anthony Sw Goh
Journal:  EJNMMI Res       Date:  2013-07-25       Impact factor: 3.138
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.